Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand
Background: Maternal antibodies, acquired passively via placenta and/or breast milk, may contribute to the reduced efficacy of oral rotavirus vaccines observed in children in developing countries. This study aimed to investigate the effect of rotavirus specific maternal antibodies on the serum IgA r...
Main Authors: | Mee-Yew Chen, Carl D. Kirkwood, Julie Bines, Daniel Cowley, Daniel Pavlic, Katherine J. Lee, Francesca Orsini, Emma Watts, Graeme Barnes, Margaret Danchin |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-05-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2016.1274474 |
Similar Items
-
Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine
by: Daniel Cowley, et al.
Published: (2017-08-01) -
Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine
by: Daniel Cowley, et al.
Published: (2018-08-01) -
Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule
by: Nicholas Geard, et al.
Published: (2022-11-01) -
Rotaviruses and Rotavirus Vaccines
by: Celeste M. Donato, et al.
Published: (2021-07-01) -
Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia
by: Eleanor Burnett, et al.
Published: (2018-05-01)